GlassScriptPhysician profile
Holly Goracke
NPI 1659695450
$5,150.66
in general payments reported to CMS, 2019-2025
44 companies · $774 in 2025
The $774 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.36 · 2020: $329 · 2021: $901 · 2022: $867 · 2023: $1,041 · 2024: $1,179 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $594.45 | 2021-2025 | |
| Lilly USA, LLC | $530.50 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $463.19 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $429.12 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $415.41 | 2022-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Astrazeneca Pharmaceuticals LP | $327.99 | 2020-2025 | Airsupra, Breztri |
| Pfizer INC. | $297.63 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.04 | 2021-2025 | Jardiance |
| Dexcom, INC. | $166.35 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $151.60 | 2023-2024 | Intellis Adaptivestim, Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $117.86 | 2021-2023 | Trintellix |
| Astellas Pharma US INC | $109.86 | 2020-2025 | Veozah |
| Amarin Pharma, INC. | $97.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $90.57 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $86.06 | 2021-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Goracke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.